or Try an Advanced Search...

    Technical Analysis for QNTM - Quantum Biopharma Ltd.

    Grade Last Price % Change Price Change
    D 5.10 1.39% 0.07
    QNTM closed up 1.39 percent on Thursday, November 21, 2024, on 22 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical QNTM trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    MACD Bearish Centerline Cross Bearish 1.39%
    50 DMA Support Bullish 1.39%
    Hammer Candlestick Bullish 1.39%
    Narrow Range Bar Range Contraction 1.39%
    Narrow Range Bar Range Contraction 3.03%
    Wide Bands Range Expansion 3.03%
    Older End-of-Day Signals for QNTM ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 5 hours ago
    Down 1% about 5 hours ago
    60 Minute Opening Range Breakdown about 6 hours ago
    10 DMA Resistance about 6 hours ago
    60 Minute Opening Range Breakout about 8 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    QNTM Chart by TradingView
    Basic chart:

    Profile

    Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biotechnology Lucid

    Is QNTM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
    Oct 22 Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
    Oct 21 Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
    Oct 21 Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
    Oct 7 Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America
    Sep 28 Quantum Biopharma Provides Corporate Update
    Sep 25 Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US
    Sep 14 Quantum BioPharma Closes Private Placement Offering
    Sep 9 Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
    Sep 9 Quantum Biopharma regains Nasdaq compliance
    See more QNTM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 89.7
    52 Week Low 3.5007
    Average Volume 78,543
    200-Day Moving Average 19.97
    50-Day Moving Average 4.83
    20-Day Moving Average 5.14
    10-Day Moving Average 5.18
    Average True Range 0.57
    RSI (14) 49.75
    ADX 29.39
    +DI 24.04
    -DI 15.15
    Chandelier Exit (Long, 3 ATRs) 5.57
    Chandelier Exit (Short, 3 ATRs) 5.72
    Upper Bollinger Bands 5.75
    Lower Bollinger Band 4.52
    Percent B (%b) 0.47
    BandWidth 23.95
    MACD Line -0.01
    MACD Signal Line 0.04
    MACD Histogram -0.0429
    Fundamentals Value
    Market Cap 200.82 Million
    Num Shares 39.4 Million
    EPS -0.58
    Price-to-Earnings (P/E) Ratio -8.79
    Price-to-Sales 91.86
    Price-to-Book 2.28
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.37
    Resistance 3 (R3) 5.36 5.25 5.32
    Resistance 2 (R2) 5.25 5.18 5.26 5.31
    Resistance 1 (R1) 5.18 5.14 5.21 5.19 5.29
    Pivot Point 5.07 5.07 5.09 5.08 5.07
    Support 1 (S1) 5.00 5.00 5.04 5.01 4.91
    Support 2 (S2) 4.89 4.96 4.90 4.89
    Support 3 (S3) 4.82 4.89 4.88
    Support 4 (S4) 4.83